Orexo´s digital therapies deliver therapeutic interventions to patients to prevent, manage, or treat a medical disorder or disease. The programs are available for patients in their own privacy 24/7 and can be used in conjunction with their ongoing treatment plans. Its efficacy has been demonstrated in numerous published clinical trials including thousands of patients.

Our digital therapies

vorvida®

evidence based digital therapy for alcohol management

Vorvida® is a 6-month online program that can break negative thought patterns and responses to change behavior around alcohol. The therapy is developed in consultation with psychologists, physicians and patients and is based on cognitive behavioural therapy techniques. The effectiveness of vorvida® is evaluated in randomized clinical trial, including approximately 600 patients.1

deprexis®

evidence based digital therapy for depression

Deprexis® is a 3-month online program that can help people create more positive thoughts and behaviors. The therapy is developed in consultation with psychologists, physicians and patients and is based on cognitive behavioural therapy techniques. Its effectiveness has been evaluated and published in 12 randomized clinical trials (RCTs) including more than 2,800 patients. Deprexis® can be used as a standalone treatment or alongside traditional pharmaceuticals.2

MODIA®

digital therapy for opioid use disorder

MODIA® is a 6-month therapy based on cognitive behavioral therapy techniques and should be used as part of a supervised medication-assisted treatment program for OUD. The therapy helps users develop a customized relapse prevention plan based on the responses collected from the exercises throughout the program.

Orexo´s digital therapeutics are developed by GAIA AG or in collaboration with GAIA AG who has long experience from developing evidence-based digital therapies within multiple therapeuitc areas. All therapies are developed in consultation with psychologists, physicians and patients and are built on techniques related to cognitive behavioral therapy (CBT).  

GAIA: a world leader in digital therapeutics

  • Proven effectiveness in numerous randomized clinical trials with over 7,000 patients
  • More than 12 years of R&D experience, 20+ CE & FDA compliant products
  • Indications - CNS, immunology, oncology

Source and image rights - GAIA AG

1 Jördis M. Zill, Eva Christalle, Björn Meyer, Martin Härter, and Jörg Dirmaier The Effectiveness of an Internet Intervention Aimed at Reducing Alcohol Consumption in Adults: Results of a Randomized Controlled Trial (Vorvida) Dtsch Arztebl Int 2019; 116: 127–33. DOI: 10.3238/arztebl.2019.0127

2 Twomey et al. (2020), Zwerenz et al. (2017), Berger et al. (2018), Beevers et al. (2017), Klein et al. (2016), Meyer et al. (2015), Moritz et al. (2012), Berger et al. (2011), Meyer et al. (2009), Bücker et al. (2018), Fischer et al. (2015), Schröder et al. (2014)